Scandion Oncology A/S
SCOL | ST
Overview
Corporate Details
- ISIN(s):
- DK0061031895 (+3 more)
- LEI:
- 549300MPWDMQ5LZEGD09
- Country:
- Denmark
- Address:
- Fruebjergvej 3, 2100 København Ø
- Website:
- https://scandiononcology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Scandion Oncology A/S focuses on overcoming cancer drug resistance. Their research targets innovative therapies for improved treatment outcomes.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Scandion Oncology A/S.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Scandion Oncology A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Scandion Oncology A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Curevac | Germany | CVAC | |
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA |